Insmed Inc [INSM] stock prices are up 1.31% to $108.69 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INSM shares have gain 4.56% over the last week, with a monthly amount glided 10.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on May 13, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $105. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on February 25, 2025, and set its price target to $100. On April 23, 2024, Truist initiated with a Buy rating and assigned a price target of $48 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $42 on February 15, 2024. Wells Fargo initiated its recommendation with a Overweight and recommended $55 as its price target on December 08, 2023. In a note dated July 26, 2023, Guggenheim initiated an Buy rating and provided a target price of $50 on this stock.
The stock price of Insmed Inc [INSM] has been fluctuating between $60.40 and $108.64 over the past year. Currently, Wall Street analysts expect the stock to reach $110 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $108.69 at the most recent close of the market. An investor can expect a potential return of 1.21% based on the average INSM price forecast.
Analyzing the INSM fundamentals
The Insmed Inc [NASDAQ:INSM] reported sales of 381.03M for trailing twelve months, representing a surge of 22.94%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -2.3%, Pretax Profit Margin comes in at -2.65%, and Net Profit Margin reading is -2.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -4.47 and Total Capital is -0.56. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 11.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 106.66 points at the first support level, and at 104.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 109.80, and for the 2nd resistance point, it is at 110.92.
Ratios To Look Out For
It’s worth pointing out that Insmed Inc [NASDAQ:INSM]’s Current Ratio is 5.86. As well, the Quick Ratio is 5.44, while the Cash Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 54.18, the price to book ratio is 199.38.
Transactions by insiders
Recent insider trading involved Bonstein Sara, Chief Financial Officer, that happened on Jul 21 ’25 when 58400.0 shares were sold. Officer, Bonstein Sara completed a deal on Jul 21 ’25 to buy 58400.0 shares. Meanwhile, Chair and CEO Lewis William sold 6830.0 shares on Jul 15 ’25.
